Health Care

Analyst EPS Forecasts Opinions about Stocks of: Boston Scientific Corporation (NYSE:BSX) , Nektar Therapeutics (NASDAQ:NKTR)

0 3

Boston Scientific Corporation (NYSE:BSX) initiated the shares trading at $23.52 and showed negative change of -0.94% while the stock’s final trade was registered at $ 23.28. However, its previous closing price was seen at $23.50. The stock negotiated total number of 5.92 million shares as compared to 3 months average volume of 8.01 million shares.

The stock price demonstrated downbeat change from its 50 day moving average of 23.81 and had been up from its 200 Day Moving Average of 22.50.

Shares of Boston Scientific Corporation (NYSE:BSX) declined -0.94% and ended at $23.28 smaller than previous closing price of $23.50. The total 5.92 million shares were bought and sold throughout the most recent trading session less than average volume of 8.01 million shares.

Presently Boston Scientific Corporation (BSX) , Analysts decided consensus EPS estimate of $0.27 for present quarter and one month ago projected EPS estimate was at $0.27. If we take a look at back 3 month ago, consensus EPS estimate was $0.27.

A current consensus EPS estimate for next quarter is at $0.29 and 3 month ago EPS forecast was $0.28. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.29.

For current fiscal year, most recent EPS estimate is set at $1.10 based on Analyst consensus and three month ago consensus EPS opinions was at $1.09. During period one month ago, consensus EPS forecast was decided at $1.10.

Nektar Therapeutics (NASDAQ:NKTR) initiated the shares trading at $17.50 and showed negative change of -3.09% while the stock’s final trade was registered at $ 16.94. However, its previous closing price was seen at $17.48. The stock negotiated total number of 886.07 thousand shares as compared to 3 months average volume of 1.2 million shares.

The stock price demonstrated downbeat change from its 50 day moving average of 18.20 and had been up from its 200 Day Moving Average of 15.88.

Shares of Nektar Therapeutics (NASDAQ:NKTR) declined -3.09% and ended at $16.94 smaller than previous closing price of $17.48. The total 886.07 thousand shares were bought and sold throughout the most recent trading session less than average volume of 1.2 million shares.

Presently Nektar Therapeutics (NKTR) , Analysts decided consensus EPS estimate of $-0.34 for present quarter and one month ago projected EPS estimate was at $-0.34. If we take a look at back 3 month ago, consensus EPS estimate was $-0.30.

A current consensus EPS estimate for next quarter is at $-0.28 and 3 month ago EPS forecast was $-0.22. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.28.

For current fiscal year, most recent EPS estimate is set at $-1.07 based on Analyst consensus and three month ago consensus EPS opinions was at $-0.95. During period one month ago, consensus EPS forecast was decided at $-1.07.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter